Growing community of inventors

Stockholm, Sweden

Birgitta Olofsson

Average Co-Inventor Count = 4.00

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 205

Birgitta OlofssonKari Alitalo (6 patents)Birgitta OlofssonUlf Eriksson (6 patents)Birgitta OlofssonKatri Pajusola (5 patents)Birgitta OlofssonTaija Makinen (1 patent)Birgitta OlofssonBirgitta Olofsson (6 patents)Kari AlitaloKari Alitalo (72 patents)Ulf ErikssonUlf Eriksson (43 patents)Katri PajusolaKatri Pajusola (9 patents)Taija MakinenTaija Makinen (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ludwig Institute for Cancer Research Limited (4 from 525 patents)

2. Other (2 from 832,912 patents)

3. Helsinki University Licensing Ltd. Oy (2 from 5 patents)

4. Licentia, Ltd. (1 from 20 patents)


6 patents:

1. 7341996 - Processed vascular endothelial growth factor-B polypeptides

2. 6515105 - Neuropilin/growth factor complexes and uses thereof

3. 6331301 - Antibodies specific for vascular endothelial growth factor-B

4. 5928939 - Vascular endothelial growth factor-b and dna coding therefor

5. 5840693 - Vascular endothelial growth factor-B

6. 5607918 - Vascular endothelial growth factor-B and DNA coding therefor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/10/2026
Loading…